# OnCo record paper-glow-zolbetuximab-nat-med-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-glow-zolbetuximab-nat-med-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-glow-zolbetuximab-nat-med-2023" ;
  schema:name "GLOW: zolbetuximab plus CAPOX in claudin 18.2-positive, HER2-negative gastric or gastro-oesophageal junction adenocarcinoma"@en ;
  schema:description "Adding the claudin 18.2 antibody zolbetuximab to CAPOX chemotherapy lengthened survival in claudin 18.2-positive advanced gastric cancer, confirming the SPOTLIGHT result with a different chemotherapy backbone."@en ;
  schema:url <https://onco.cc/key-papers/paper-glow-zolbetuximab-nat-med-2023/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41591-023-02465-7>, <https://pubmed.ncbi.nlm.nih.gov/37524953/> ;
  schema:sameAs <https://doi.org/10.1038/s41591-023-02465-7> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Shah MA, Shitara K, Ajani JA, et al." ;
  onco:cancers <https://onco.cc/cancers/gastric-cldn18-2-positive/> ;
  onco:drugs <https://onco.cc/drugs/zolbetuximab/> ;
  onco:journals <https://onco.cc/journals/nature-medicine/> .